Walleye Capital LLC Catalent, Inc. Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $2.92 Million - $4.1 Million	-68,500 Reduced 57.56%	50,500 $2.85 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $2.64 Million - $3.82 Million	82,100 Added 222.49%	119,000 $5.35 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $574,600 - $652,600	13,000 Added 54.39%	36,900 $1.68 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $608,526 - $1.28 Million	19,100 Added 397.92%	23,900 $1.04 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $177,216 - $289,614	3,900 Added 433.33%	4,800 $315,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $37,251 - $72,900	900 New	900 $40,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.